Who owns intuitive surgical
Outside of the U. Ion cannot be placed on the market or put into service. Ion may not have regulatory approvals in all markets. Please check with your local Intuitive representative. Risks associated with bronchoscopy through an endotracheal tube and under general anesthesia are infrequent and typically minor, and may include but are not limited to: sore throat, hoarseness, respiratory complications including dyspnea or hypoxemia, airway injury, bronchospasm, laryngospasm, fever, hemoptysis, chest or lung infection including pneumonia, lung abscess or an adverse reaction to anesthesia.
Although rare, the following complications may also occur: bleeding, pneumothorax collapsed lung , cardiac related complications, respiratory failure, air embolism, or death. The Ion Endoluminal System Model IF assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures.
The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use. About Intuitive Helping people get back to what matters most. Pairing human ingenuity with technology. Procedures performed worldwide through using da Vinci systems. Countries with da Vinci systems. To date, the family of da Vinci technologies has been used by surgeons in all 50 U.
The Ion endoluminal system is a robotic-assisted endoscopy platform designed to enable the biopsy of small, hard-to-reach lung nodules when lung cancer is suspected. Decades of da Vinci system innovation have enabled us to offer physicians this minimally invasive platform to support early lung cancer detection. Patients should talk to their doctor to decide if da Vinci surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options and associated risks in order to make an informed decision.
Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use, please also refer to www.
Designed to enhance surgeon capabilities. Data Disclaimer Help Suggestions. Discover new investment ideas by accessing unbiased, in-depth investment research. Marshall L. Myriam J. Curet McAdams F. Robert DeSantis. Jamie E. VP of Fin. Director of IR. Head of Investor Relations. Kara Andersen Reiter.
0コメント